Navigation Links
DNA OligoMix from LC Sciences

ProductsDNA OligoMix from LC Sciences
Company LC Sciences
Item DNA OligoMix
Price 
Description LC Sciences provides a unique new tool, OligoMix for low cost, high throughput DNA synthesis serving diverse needs in genomics, proteomics, synthetic biology, drug discovery, and microarray applications. OligoMix is a MIXTURE of a large number of DESIGNED synthetic DNA oligonucleotide sequences delivered in a single microtube. OligoMix is made from an innovative method of synthesis (1,2) and costs our customers 20 less per base than conventional synthesis.

OligoMix may contain any customer defined sequences (up to ~90 nts in length), OH, phosphate, or other types of 5 terminal groups, and OH or phosphate 3 terminal groups. Send us your sequences and in one-two weeks we deliver the OligoMix in pmol quantities ready for your applications such as hybridization, amplification, primer extension, and ligation.

We offer additional services for OligoMix: bioinformatics for sequence design, purification, sequence verification, preparation in duplex forms and restriction fragments, increasing product amount to nmol or more quantities, cloning and sequencing, and transcription into RNA OligoMix or individual RNA sequences. Visit our web site for more information about this product and the powerful genomic applications of OligoMix.

Economical
At less than 0.8 per base, DNA OligoMix contains thousands to millions of sequences and costs 20 less than conventional synthesis; savings is even more dramatic on long sequences.

Simple
Simply email your sequences in a text or Excel format and obtain synthesized sequences quickly. All sequences are delivered in one tube significantly increasing your experimental throughput. There is no need for robotic liquid handling or a large storage space.

Customizable
Based on conventional DMT nucleotide chemistry, our synthesis technology is very flexible and you may incorporate nucleotide modifications to suit your specific needs. Incorporation of nucleotide modifications substantially increases the number of applications of this product.

LC Sciences
LC Sciences is a genomics and proteomics company offering innovative and customizable products based on the Paraflo microfluidic technology. We offer unique products for construction of biomolecular libraries containing up to millions of different biomolecules of defined sequences. These products significantly reduce the cost and increase the speed of highly multiplexing genome-scale experiments such as exploration of small RNAs and designer gene/DNA library synthesis.

We additionally offer comprehensive microarray services for nucleic acid/protein profiling and functional analysis, biomarker-discovery, novel drug screening, and the custom development of diagnostic devices. Our microarray services offer standard and custom synthesized microarrays based on the Paraflo on-chip synthesis technology (1,2) which enables the high quality microarray synthesis and total customization of sequence content and incorporation of modifications.

(1) Tian, J., Gong, H., Sheng, N., Zhou, X., Gulari, E., Gao, X., and Church, G. (2004) Accurate multiplex gene synthesis from programmable DNA chips. Nature 432, 1050-1054.

(2) Zhou, X., Cai, S., Hong, A., Yu, P., Sheng, N., Srivannavit, O., Yong, Q., Muranjan, S., Rouillard, J. M., Xia, Y., Zhang, X., Xiang, Q., Ganesh, R., Zhu, Q., Makejko, A., Gulari, E., and Gao, X. (2004) Microfluidic picoarray synthesis of oligodeoxynucleotides and simultaneously assembling of multiple DNA sequences. Nucleic Acids Res. 32, 5409-5417.
Info LC SciencesLC Sciences
2575 W. Bellfort
Suite 270
Houston, TX 77054

Call LC Sciences to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-713-574-7399
Customer Service: (713) 664-7087 or Toll Free: (888) 528-8818
Fax Number: (713) 664-8181
Web Site: http://www.lcsciences.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. RNA OligoMix from LC Sciences
2. DNA/RNA Aptamer Microarray - Comprehensive Service from LC Sciences
3. Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
4. Protein Kinase Substrate (PKS) Peptide Microarray - Comprehensive Service from LC Sciences
5. Small Non-coding RNA Discovery Microarray - Comprehensive Service from LC Sciences
6. Custom 2-OMe RNA Aptamer Microarray from LC Sciences
7. Custom DNA Aptamer Microarray from LC Sciences
8. Epitope Peptide Microarray - Comprehensive Service from LC Sciences
9. Custom 2-F RNA Aptamer Microarray from LC Sciences
10. Custom Peptide Microarray - Comprehensive Service from LC Sciences
11. Standard DNA Aptamer Microarray from LC Sciences
Immunogen: Synthetic peptide: N(171) H G F L S A D Q QL I K(183) Storage: -20 C, Avoid Freeze/Thaw Cycles...
The pCDF Expression System 1 plus Competent Cells contains 10 µg of pET-45b(+) DNA. pET-45b carries an N-terminal His•Tag ® coding sequence that is cleavable with enterokinase as well...
HIV-1 TAT (vN-21)...
Request Info...
Biology Products:
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first ... post-password and Internet of Things era, today announced the ... venture round was led by Metamorphic Ventures with participation ... Partners, VegasTechFund, and others.  LaunchKey has raised $4 million ... expand its team and bring LaunchKey to market in ...
(Date:12/17/2014)... DUBLIN , Dec. 16, 2014 Research ... announced the addition of the "Global Chemical ... http://photos.prnewswire.com/prnh/20130307/600769 ... is the increasing demand for medical sensors in ... patient data for quick and correct diagnosis during ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... our way out of ageing," says Nancy Ross, a McGill geography ... maybe some hearing loss, maybe lose some mobility ageing is ... lead author of a new study about how socio-economic and educational ... a lifetime. "My research looks at how poverty ...
... type of gorilla will receive a helping hand from Newman,s ... $150,000 grant to help save the Grauer,s gorilla in the ... The grant will help equip and support park rangers (or ... National Park, a World Heritage site that is now threatened ...
... This press release is available in German . ... diseases: the minute soot particles from the exhaust gas of ... In order to nevertheless keep the harmful effects to one,s ... for diesel soot have been lowered drastically step by step, ...
Cached Biology News:Lifelong gap in health between rich and poor set by age 20 2Wildlife Conservation Society receives $150,000 grant from Newman's Own Foundation to save gorillas 2Pan-European research project for clean air 2Pan-European research project for clean air 3
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 iLab ... announced the appointment of Siri Bryant as the new ... new Director of Core Implementations. These two new leadership ... outstanding customer service by ensuring that iLab continues to ... “In the last four years, iLab has been deployed ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 18, 2014  Decision ... dental biomaterial market will grow moderately through ... implant procedures and growing awareness of dental biomaterials all ... underdeveloped markets such as China ... incomes will bring dental procedures within reach for a ...
(Date:12/17/2014)... (PRWEB) December 16, 2014 The ... since 2013, which is why IBISWorld updated its original ... continues to benefit from an intensified focus on environmental ... for new emission standards for power plants and a ... According to IBISWorld Industry Analyst Sarah Kahn, “a range ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
Breaking Biology Technology:iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8